Banks, asset managers, payments networks, insurers, fintech, crypto-linked companies, and the capital markets around them.
Mastercard says it is backing Open USD, a consortium stablecoin aimed at faster, lower-cost digital payments, as investors weigh what the move could mean for the payments giant’s long-term strategy and valuation.
THE APEX TIMES
THE APEX TIMES
Gemini (GEMI) started offering commission-free, exchange-listed stock trades in the U.S. through the Gemini app, a move that puts the crypto exchange directly in the equities market. Despite the launch, GEMI shares fell in early trading as the broader market mood turned cautious.
THE APEX TIMES
A recent market note flagged that Visa’s stock has moved in a narrow range and lagged major indexes over the past six months, even as the company’s underlying economics remain a central part of the bull case.
THE APEX TIMES
A new report says Coinbase co-founder and CEO Brian Armstrong reacted with a single-word response to a sheriffs group’s sudden change in stance, as the industry continues pushing for U.S. legislation aimed at creating clearer rules for digital assets.
THE APEX TIMES
Mastercard reported accelerating services growth and strong margin performance in its latest quarter, while PayPal showed a downturn in net income even as it cleared expectations. The contrast is fueling a renewed debate about which payment business offers a clearer valuation setup.
THE APEX TIMES
Berkshire has begun a more active approach under CEO Greg Abel, including a new position in Macy’s that the retailer says reflects its “Bold New Chapter” turnaround plan.
THE APEX TIMES
Ahead of its next results, Wall Street is positioning JPMorgan Chase as a key read-through for how loan demand, trading activity, and capital markets revenue are holding up.
THE APEX TIMES
A fresh earnings preview centers on whether higher revenues can translate into an increase in earnings for the quarter Goldman Sachs is set to report.
THE APEX TIMES
Ahead of SpaceX’s expected addition to the Nasdaq-100, analysts at Goldman Sachs and Morgan Stanley issued sharply divergent valuation views, with Goldman’s $205 target contrasting with Morgan Stanley’s $300.
